News
7 August 2019
Country News
Clinical trials of the domestic Tianox device for nitrogen oxide therapy for various diseases in children and adults have begun at the Almazov NMIC Federal State Budgetary Institution. The device can be used in intensive care units, anesthesiology-intensive care units, cardiology centers, neonatology departments and perinatal centers. The development is protected by five Russian patents.